The aim of this study was to investigate whether the expression of survivin correlates with histopathological grade and compare the clinical usefulness with the 2016 WHO classification and MIB-1 biomarker as a predictor of meningioma recurrence after initial surgery. Here, BIRC5 is linked to meningioma.